Antu Eapan Thomas
Stock Analyst at Geojit Research
(1.11)
# 3,719
Out of 4,575 analysts
44
Total ratings
43.6%
Success rate
-2%
Average return
Main Sectors:
Stocks Rated by Antu Eapan Thomas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹2,660 | ₹2,512 | +5.89% | 1 | Jun 16, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Reiterated: Buy | ₹1,150 | ₹946.00 | +21.56% | 1 | Jun 15, 2026 | |
| NSE: PVRINOX PVR INOX Limited | Maintained: Buy | ₹1,065 → ₹1,189 | ₹1,055 | +12.70% | 2 | Jun 5, 2026 | |
| NSE: RAINBOW Rainbow Children's Medicare Limited | Initiated Coverage: Buy | ₹1,679 | ₹1,468 | +14.37% | 1 | May 27, 2026 | |
| NSE: SBICARD SBI Cards and Payment Services Limited | Maintained: Buy | ₹950.00 → ₹698.00 | ₹618.20 | +12.91% | 2 | May 18, 2026 | |
| NSE: LICI Life Insurance Corporation of India | Reiterated: Buy | ₹544.00 → ₹467.00 | ₹421.80 | +10.72% | 3 | Mar 18, 2026 | |
| NSE: NBCC NBCC (India) Limited | Rated: Hold | n/a | $93.95 | - | 1 | Mar 17, 2026 | |
| NSE: GODREJPROP Godrej Properties Limited | Maintained: Buy | ₹2,096 | ₹2,050 | +2.23% | 1 | Feb 26, 2026 | |
| NSE: AMBER Amber Enterprises India Limited | Initiated Coverage: Buy | ₹9,156 | ₹7,250 | +26.29% | 1 | Feb 23, 2026 | |
| NSE: HCG HealthCare Global Enterprises Limited | Upgraded: Buy | ₹628.00 → ₹724.00 | ₹667.00 | +8.55% | 2 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹780.00 | ₹795.00 | -1.89% | 1 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,180 | ₹1,080 | +9.27% | 1 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹568.00 → ₹791.00 | ₹264.95 | +198.55% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹686.00 | ₹574.55 | +19.40% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹4,409 → ₹4,560 | ₹3,788 | +20.38% | 2 | Feb 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹857.00 → ₹828.00 | ₹555.80 | +48.97% | 4 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,244 → ₹2,080 | ₹1,665 | +24.92% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹312.00 → ₹439.00 | ₹434.20 | +1.11% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ₹1,076 | ₹1,012 | +6.32% | 1 | Jan 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,085 | ₹1,016 | +6.79% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,254 | ₹1,851 | +21.75% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,790 → ₹1,613 | ₹1,555 | +3.73% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,015 | ₹815.00 | +24.54% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,820 | ₹1,369 | +32.94% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,791 → ₹1,247 | ₹542.00 | +130.07% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹3,691 | ₹2,250 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹386.00 | ₹238.81 | n/a | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,770 | ₹725.00 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹326.00 | ₹310.00 | n/a | 1 | Dec 10, 2024 |
Mankind Pharma Limited
Jun 16, 2026
Maintained: Buy
Price Target: ₹2,660
Current: ₹2,512
Upside: +5.89%
Fortis Healthcare Limited
Jun 15, 2026
Reiterated: Buy
Price Target: ₹1,150
Current: ₹946.00
Upside: +21.56%
PVR INOX Limited
Jun 5, 2026
Maintained: Buy
Price Target: ₹1,065 → ₹1,189
Current: ₹1,055
Upside: +12.70%
Rainbow Children's Medicare Limited
May 27, 2026
Initiated Coverage: Buy
Price Target: ₹1,679
Current: ₹1,468
Upside: +14.37%
SBI Cards and Payment Services Limited
May 18, 2026
Maintained: Buy
Price Target: ₹950.00 → ₹698.00
Current: ₹618.20
Upside: +12.91%
Life Insurance Corporation of India
Mar 18, 2026
Reiterated: Buy
Price Target: ₹544.00 → ₹467.00
Current: ₹421.80
Upside: +10.72%
NBCC (India) Limited
Mar 17, 2026
Rated: Hold
Price Target: n/a
Current: $93.95
Upside: -
Godrej Properties Limited
Feb 26, 2026
Maintained: Buy
Price Target: ₹2,096
Current: ₹2,050
Upside: +2.23%
Amber Enterprises India Limited
Feb 23, 2026
Initiated Coverage: Buy
Price Target: ₹9,156
Current: ₹7,250
Upside: +26.29%
HealthCare Global Enterprises Limited
Feb 19, 2026
Upgraded: Buy
Price Target: ₹628.00 → ₹724.00
Current: ₹667.00
Upside: +8.55%
Feb 19, 2026
Maintained: Buy
Price Target: ₹780.00
Current: ₹795.00
Upside: -1.89%
Feb 16, 2026
Upgraded: Buy
Price Target: ₹1,180
Current: ₹1,080
Upside: +9.27%
Feb 11, 2026
Reiterated: Buy
Price Target: ₹568.00 → ₹791.00
Current: ₹264.95
Upside: +198.55%
Feb 10, 2026
Maintained: Buy
Price Target: ₹686.00
Current: ₹574.55
Upside: +19.40%
Feb 1, 2026
Reiterated: Buy
Price Target: ₹4,409 → ₹4,560
Current: ₹3,788
Upside: +20.38%
Jan 29, 2026
Reiterated: Buy
Price Target: ₹857.00 → ₹828.00
Current: ₹555.80
Upside: +48.97%
Jan 28, 2026
Maintained: Buy
Price Target: ₹2,244 → ₹2,080
Current: ₹1,665
Upside: +24.92%
Jan 2, 2026
Upgraded: Buy
Price Target: ₹312.00 → ₹439.00
Current: ₹434.20
Upside: +1.11%
Jan 1, 2026
Downgraded: Hold
Price Target: ₹1,076
Current: ₹1,012
Upside: +6.32%
Nov 11, 2025
Upgraded: Buy
Price Target: ₹1,085
Current: ₹1,016
Upside: +6.79%
Nov 10, 2025
Maintained: Buy
Price Target: ₹2,254
Current: ₹1,851
Upside: +21.75%
Nov 7, 2025
Maintained: Buy
Price Target: ₹1,790 → ₹1,613
Current: ₹1,555
Upside: +3.73%
Oct 31, 2025
Maintained: Buy
Price Target: ₹1,015
Current: ₹815.00
Upside: +24.54%
Oct 31, 2025
Upgraded: Buy
Price Target: ₹1,820
Current: ₹1,369
Upside: +32.94%
Oct 8, 2025
Reiterated: Buy
Price Target: ₹1,791 → ₹1,247
Current: ₹542.00
Upside: +130.07%
Jul 15, 2025
Reiterated: Buy
Price Target: ₹3,691
Current: ₹2,250
Upside: n/a
Jun 9, 2025
Maintained: Buy
Price Target: ₹386.00
Current: ₹238.81
Upside: n/a
Apr 2, 2025
Maintained: Hold
Price Target: ₹2,770
Current: ₹725.00
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: ₹326.00
Current: ₹310.00
Upside: n/a